Kimalisa Locklear

NPI: 1306482500
Total Payments
$24,256
2024 Payments
$11,661
Companies
25
Transactions
155
Medicare Patients
1,274
Medicare Billing
$315,351

Payment Breakdown by Category

Other$20,543 (84.7%)
Food & Beverage$2,650 (10.9%)
Travel$961.97 (4.0%)
Education$100.00 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Long term medical supply or device loan $20,543 7 84.7%
Food and Beverage $2,650 142 10.9%
Travel and Lodging $961.97 5 4.0%
Education $100.00 1 0.4%

Top Paying Companies

Company Total Records Latest Year
AngioDynamics, Inc. $20,663 9 $0 (2024)
Bard Peripheral Vascular, Inc. $1,190 9 $0 (2024)
Janssen Pharmaceuticals, Inc $412.83 31 $0 (2024)
Merck Sharp & Dohme LLC $304.28 19 $0 (2024)
Amgen Inc. $288.34 18 $0 (2024)
PFIZER INC. $204.80 14 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $176.57 8 $0 (2024)
Novo Nordisk Inc $176.40 4 $0 (2023)
Novartis Pharmaceuticals Corporation $160.77 11 $0 (2024)
SCPHARMACEUTICALS INC. $160.20 3 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $11,661 38 AngioDynamics, Inc. ($9,900)
2023 $11,613 52 AngioDynamics, Inc. ($10,743)
2022 $443.84 28 Merck Sharp & Dohme LLC ($99.27)
2021 $537.79 37 Janssen Pharmaceuticals, Inc ($131.50)

All Payment Transactions

155 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
12/31/2024 AngioDynamics, Inc. Auryon Laser System 100-120 Vac (Device) Long term medical supply or device loan In-kind items and services $7,500.00 General
Category: ET
12/31/2024 AngioDynamics, Inc. VenaCure 1470 Pro (Device) Long term medical supply or device loan In-kind items and services $1,200.00 General
Category: ET
12/31/2024 AngioDynamics, Inc. VenaCure 1470 Pro (Device) Long term medical supply or device loan In-kind items and services $1,200.00 General
Category: ET
12/10/2024 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $17.67 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/16/2024 Kestra Medical Technology Services, Inc. Assure WCD (Device) Food and Beverage Cash or cash equivalent $13.30 General
Category: Cardiology
10/10/2024 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $17.66 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/24/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $14.04 General
Category: CARDIOVASCULAR
09/19/2024 Organogenesis Inc. APLIGRAF (Device) Food and Beverage In-kind items and services $38.59 General
Category: WOUND CARE
09/10/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $16.58 General
Category: Cardiovascular
08/27/2024 Alnylam Pharmaceuticals Inc. Food and Beverage In-kind items and services $16.06 General
08/15/2024 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $14.21 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/06/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $14.87 General
Category: Cardiology
08/01/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $27.49 General
Category: DIABETES
07/30/2024 SCPHARMACEUTICALS INC. FUROSCIX (Drug) Food and Beverage In-kind items and services $19.12 General
Category: Cardiology
07/29/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $16.03 General
Category: Cardiovascular & Metabolism
07/12/2024 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $14.37 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
06/20/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $24.62 General
Category: DIABETES
06/11/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $20.66 General
Category: Cardiology
06/05/2024 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $13.36 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
05/30/2024 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $14.47 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
05/14/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $14.95 General
Category: Cardiology
04/23/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $21.43 General
Category: Cardiology
04/03/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $13.18 General
Category: Cardiovascular & Metabolism
03/21/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $17.19 General
Category: DIABETES
03/11/2024 Bard Peripheral Vascular, Inc. Venclose Maven Catheter (Device) Travel and Lodging In-kind items and services $147.39 General
Category: Vascular/Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 252 411 $890,064 $113,762
2022 6 273 407 $1.1M $151,248
2021 4 266 394 $99,156 $23,583
2020 6 483 538 $124,909 $26,759
Total Patients
1,274
Total Services
1,750
Medicare Billing
$315,351
Procedure Codes
22

All Medicare Procedures & Services

22 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
36478 Laser destruction of incompetent vein of arm or leg using imaging guidance Office 2023 70 147 $735,000 $89,749 12.2%
36475 Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance Office 2023 16 16 $96,000 $10,878 11.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 76 137 $41,785 $9,855 23.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 15 15 $7,020 $1,551 22.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 20 23 $4,784 $1,157 24.2%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 55 73 $5,475 $571.89 10.4%
36478 Laser destruction of incompetent vein of arm or leg using imaging guidance Office 2022 85 168 $840,000 $110,454 13.1%
36475 Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance Office 2022 37 40 $240,000 $29,014 12.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 69 108 $32,940 $8,377 25.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 14 14 $6,552 $1,524 23.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 23 26 $5,408 $1,445 26.7%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 45 51 $3,825 $433.74 11.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 108 210 $64,050 $16,690 26.1%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 40 40 $18,720 $3,819 20.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 33 42 $8,736 $2,179 24.9%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 85 102 $7,650 $895.56 11.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 251 296 $90,280 $20,036 22.2%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 33 33 $15,444 $3,289 21.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 42 45 $9,360 $1,863 19.9%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2020 117 119 $8,925 $1,294 14.5%
80061 Blood test, lipids (cholesterol and triglycerides) Office 2020 12 14 $280.00 $184.22 65.8%
36415 Insertion of needle into vein for collection of blood sample Office 2020 28 31 $620.00 $92.10 14.9%

About Kimalisa Locklear

Kimalisa Locklear is a Nurse Practitioner healthcare provider based in Fayetteville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2019. The National Provider Identifier (NPI) number assigned to this provider is 1306482500.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kimalisa Locklear has received a total of $24,256 in payments from pharmaceutical and medical device companies, with $11,661 received in 2024. These payments were reported across 155 transactions from 25 companies. The most common payment nature is "Long term medical supply or device loan" ($20,543).

As a Medicare-enrolled provider, Locklear has provided services to 1,274 Medicare beneficiaries, totaling 1,750 services with total Medicare billing of $315,351. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Location Fayetteville, NC
  • Active Since 11/22/2019
  • Last Updated 11/22/2019
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1306482500

Products in Payments

  • Auryon Laser System 100-120 Vac (Device) $15,020
  • VenaCure 1470 Pro (Device) $5,643
  • Venclose Maven Catheter (Device) $1,190
  • XARELTO (Drug) $412.83
  • VERQUVO (Drug) $304.28
  • Repatha (Biological) $288.34
  • ELIQUIS (Drug) $236.43
  • JARDIANCE (Drug) $176.57
  • FUROSCIX (Drug) $160.20
  • ENTRESTO (Drug) $86.06
  • LEQVIO (Drug) $74.71
  • Kerendia (Drug) $60.87
  • BRILINTA (Drug) $46.45
  • Arcalyst (Drug) $42.87
  • FARXIGA (Drug) $39.17
  • APLIGRAF (Device) $38.59
  • Ozempic (Drug) $34.87
  • Inpefa (Drug) $33.22
  • OPSUMIT (Drug) $25.54
  • General - Therapies (Device) $24.56

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Fayetteville